HENNOS - Pharmacom Labs

Cardarine or GW501516 operates by triggering the PPAR delta receptor to utilize fatty acids as fuel instead of carbohydrates. This results, in increased stamina and weight loss  making it a popular choice among athletes wanting to enhance performance without losing muscle mass.  Although it demonstrated potential in metabolic research its advancement was halted following concerns about cancer causing effects, from prolonged usage hindering its development as a therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HENNOS by Pharmacom Labs, consult with your doctor or healthcare professional.